相关实验视频
Updated: Sep 10, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
在中风中对外体治疗的叙述性回顾:促进神经保护和再生
Muhammad Liaquat Raza1, Masooma Fatima2, Mohadisa Asif Rawalia2
1Department of Infection Prevention Control, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
通过减少炎症和氧化应激,促进神经修复,对治疗缺血性中风充满希望. 这些细胞外囊泡比中风恢复的细胞疗法具有优势.
科学领域:
- 神经科学
- 复原医学
- 生物技术
背景情况:
- 缺血性中风是由于神经炎症和神经组织再生有限而导致的严重残疾.
- 细胞外囊泡 (EVs),特别是外体,正在研究神经疾病的治疗潜力.
- 外体具有免疫调节和神经保护作用, 对于中风后恢复至关重要.
研究的目的:
- 在中风治疗中审查外体生物发生,载荷和机制.
- 在临床前和临床模型中评估外体介导的神经保护和神经发生.
- 分析基于外体治疗缺血性中风的转化潜力和优势.
主要方法:
- 对缺血性中风的外体治疗的文献叙述.
- 对外体载荷 (miRNA,蛋白质,脂质) 和它们的功能进行分析.
- 在中风模型中对外体有效性的临床前和临床研究的评估.
主要成果:
- 外体通过特定的载荷促进神经保护和修复,包括miRNAs (例如miR-124) 和蛋白质 (例如HSP70).
- 外体调节免疫反应并减少神经组织中缺血后的氧化应激.
- 外基因组疗法比基于细胞的疗法具有潜在的优势,包括安全性和存储稳定性.
结论:
- 异构体是治疗缺血性中风的有希望的策略, 增强神经修复和减少炎症.
- 需要进一步的研究来优化外体隔离,向和临床翻译的安全性.
- 基于外体的疗法有可能成为下一代中风干预和个性化医疗.
更多相关视频
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
相关概念视频
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Neurogenesis and Regeneration of Nervous Tissue